Faes Farma (XMAD:FAE) Change In Receivables : €0.0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Faes Farma Change In Receivables?

Faes Farma's change in receivables for the quarter that ended in Jun. 2023 was €0.0 Mil. It means Faes Farma's Accounts Receivable stayed the same from Mar. 2023 to Jun. 2023 .

Faes Farma's change in receivables for the fiscal year that ended in Dec. 2023 was €0.9 Mil. It means Faes Farma's Accounts Receivable declined by €0.9 Mil from Dec. 2022 to Dec. 2023 .

Faes Farma's Accounts Receivable for the quarter that ended in Jun. 2023 was €120.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Faes Farma's Days Sales Outstanding for the three months ended in Jun. 2023 was 103.64.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Faes Farma's liquidation value for the three months ended in Jun. 2023 was €92.2 Mil.

Faes Farma Change In Receivables Historical Data

The historical data trend for Faes Farma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Change In Receivables Chart

Faes Farma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-7.31

-11.38

-3.80

-1.10

0.94

Faes Farma Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Faes Farma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Faes Farma (XMAD:FAE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Faes Farma's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	120.557	/	106.143	*	91
=	103.64

2. In Ben Graham's calculation of liquidation value, Faes Farma's accounts receivable are only considered to be worth 75% of book value:

Faes Farma's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	46.515	-	110.663	+	0.75 * 120.557	+	0.5 * 131.944
=	92.2

Faes Farma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Faes Farma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Faes Farma (XMAD:FAE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (XMAD:FAE) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

0K9H:UK FFEA:Germany

Address

Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940

Website

http://www.faes.es

Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (XMAD:FAE) Headlines

No Headlines